DIVO's trailing yield overstates its committed forward rate by 30%, built on discretionary year-end specials the fund has never guaranteed to repeat.
DIVO, DGRO, and MAIN all show gaps between trailing and forward income, inflating the look-back for most of the portfolio's weight.
Duke Energy and Southern Company, the smallest 5% positions, are the only holdings with predictable scheduled dividend raises a retiree can count on to the penny.
Read More: Learn 7 ways to generate income with a $1,000,000+ portfolio (sponsor)
Replacing $8,600 a month, or roughly $103,200 a year, with portfolio income at age 61 sounds pretty straightforward on paper. But here's the catch: the biggest holding in a popular seven-fund income sleeve is the one whose payout the fund has never actually promised.

#income #fund #divo #main

XPO, Inc. (NYSE:XPO) reported that preliminary August 2026 North American less-than-truckload, or LTL, tonnage per day increased 3.7% from a year earlier. Shipments per day rose 5.7%, while average weight per shipment declined 1.8%. Final July figures showed tonnage per day increasing 5.8%, shipments per day rising 5.9%, and weight per shipment slipping 0.2%.
The two months indicate stronger shipment activity, but August's wider gap between shipment and tonnage growth points to lighter freight. The investment question is whether XPO, Inc. (NYSE:XPO) can convert additional shipments into better network density and fixed-cost absorption without allowing extra handling costs to dilute margins.
Higher shipment counts can improve the utilization of routes, service centers, dock doors, and equipment. XPO, Inc. (NYSE:XPO) operates an ****** et-based North American LTL network that moves approximately 16 billion pounds of freight annually. More shipments moving through that infrastructure can spread terminal, technology, and equipment costs across a larger revenue base.
The second quarter provides evidence that XPO, Inc. (NYSE:XPO) has recently translated volume and pricing growth into stronger economics. North American LTL revenue increased 15.2% to $1.43 billion. Fuel-surcharge revenue accounted for part of that increase, rising to $314 million from $183 million. Separately, yield excluding fuel increased 4.4%, shipments per day rose 2.8%, and tonnage per day increased 1.0%.
XPO, Inc. (NYSE:XPO) reported a company-defined non-GAAP adjusted operating ratio of 79.9%, an improvement of 300 basis points. XPO, Inc. (NYSE:XPO) calculates adjusted operating ratio as one minus adjusted operating income divided by segment revenue, using unrounded amounts. Adjusted operating income removes amortization and restructuring costs and adjusts for gains on real estate transactions. XPO, Inc. (NYSE:XPO) also reported a damage claims ratio below 0.2%.

#adjusted #north #operating

Updated Sept 09, 2026, 11:57 am EDT / Original Sept 08, 2026, 4:43 pm EDT
On the heels of its biggest acquisition to date, IonQ used its investor day to showcase its expanding presence in the quantum sector, including new product rollouts and a boost to its financial outlook.
Copyright ©2026 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

#ionq #reserved

AVGO is already designing OpenAI's third-generation XPU, with Hock Tan projecting $115 billion in AI revenue for 2027 and $230 billion in 2028.
Samsung's role in OpenAI's next-gen chips remains unspecified, whether in memory, fabrication, or design, and only a design mandate for Jalapeno's successor would truly threaten Broadcom.
AVGO trades at 19 times forward earnings against a $533 ***** yst consensus price target, backed by 45 Buy or Strong Buy ratings versus just 4 Holds.
Just released. Our ***** ysts combed the entire stock market and named the ten best stocks to buy right now, and Broadcom didn't make the cut. Enter your email to see the names that beat AVGO. The report is free. Enter your email and see if any of your stocks made the cut.
Broadcom's (NASDAQ:AVGO) position inside OpenAI became one of the most valuable customer relationships in semiconductors in June, when OpenAI unveiled Jalapeno, its first custom AI inference chip, developed with Broadcom. That work put Broadcom inside a customer that could become one of the largest silicon buyers on the planet.

#avgo #billion #stocks #email

Impax **** et Management, based in London and specializing in sustainable investing, released its Q2 2026 investor letter for the "Impax US Sustainable Economy Fund". The letter can be downloaded here. The US Sustainable Economy portfolio outperformed the Russell 1000 in Q2 2026, with Institutional Class at 17.96%, Investor Class at 17.95%, and Class A at 17.92%, versus the index's 15.14%. Sector allocation and stock selection drove performance. The sustainability tools, including the Impax Sustainability Lens and Corporate Resilience framework, contributed positively. Equity markets rallied, with both the S&P 500 and Nasdaq reaching new highs before retreating. A key trend was rotation into AI and tech stocks, supported by mega-cap earnings and data center investments (US$750bn to US$1tn). In the second half of 2026, markets may remain volatile amid debates on AI adoption pace and economic momentum. However, growth tied to energy security and efficiency remains compelling, with demand for power, grid, and resource-efficient solutions supporting companies that benefit. The team focuses on businesses with strong growth, sound management, and attractive valuations, adjusting holdings as needed. This approach aims to build well-diversified, differentiated portfolios. Also, please check the fund's top five holdings for its best picks in 2026.
In its second-quarter 2026 investor letter, Impax US Sustainable Economy Fund highlighted Micron Technology, Inc. (NASDAQ:MU) as a material contributor to performance. Micron Technology, Inc. is a leading semiconductor company that manufactures memory and storage products, delivering solutions for a wide range of applications. On September 04, 2026, Micron Technology, Inc. (NASDAQ:MU) closed at $1,016.59 per share. The one-month return of Micron Technology, Inc. (NASDAQ:MU) was 18.07% and its shares gained 673.31% over the past 52 weeks. Micron Technology, Inc. (NASDAQ:MU) has a market capitalization of $1.15 trillion.
Impax US Sustainable Economy Fund stated the following regarding Micron Technology, Inc. (NASDAQ:MU) in its Q2 2026 investor letter:
"Micron Technology, Inc. (NASDAQ:MU) (Semiconductors, Information Technology) is held for its high Sustainability Lens opportunity profile across Digital Infrastructure, Meeting Basic Needs and Education themes, and carries a strong Corporate Resilience score. The stock surged during the quarter as demand for high-bandwidth memory used in AI training and inference applications accelerated sharply. The data center build-out by hyperscale providers drove a significant uplift to Micron's pricing power and volume outlook, and the company revised its forward guidance meaningfully higher, prompting a sharp re-rating from investors."

#NASDAQ #sustainable #economy #class

CNBC reported that Apple Inc. (NASDAQ:AAPL) announced new Mac Mini and Mac Studio models with updated chips built for AI workloads.
The Mac Mini now offers Apple's new M6 chip, its first built on a 2-nanometer process, or an M5 Pro, and starts at $899, up from $799 for the prior model. Apple says the M6 delivers 4 times faster AI performance and 2 times faster graphics than the M4 model it replaces, while the M5 Pro can process large language model prompts up to 8.5 times faster than the M2 Pro version. The Mac Studio now starts at $2,499 with the M5 Max chip or $5,499 with the new M5 Ultra, up from $5,299 for the prior Ultra model, and multiple M5 Ultra units can be linked together to pool memory for running large AI models. "With these frameworks and new chips, developers can run and fine-tune large AI models locally on their Mac," Apple said. Preorders opened Tuesday, with units shipping September 22.
The performance gains here are substantial, not incremental. The M6 chip delivers 4 times faster AI performance and is Apple Inc. (NASDAQ:AAPL)'s first chip built on a 2-nanometer process. The M5 Pro configuration processes large language model prompts 8.5 times faster than the model it replaces, Apple's own specifications show, giving Apple genuine technical claims to back its AI-focused marketing.
Apple is showing pricing power even as component costs rise industry-wide. Despite memory and silicon shortages pushing costs higher across the industry, Apple raised prices on both product lines rather than absorbing the cost pressure itself. It is a sign the company believes demand can bear higher price points.
These desktops are becoming more strategically important to Apple than their revenue alone suggests. It shows how Mac desktops have become a foothold in the AI development world for Apple. It is a showcase for its custom silicon that can influence which platform developers build AI tools on and an ecosystem benefit that extends beyond the sale of any individual machine.

#faster #chip #ultra

Moneywise and Yahoo Finance LLC may earn commission or revenue through links in the content below.
For millions of Americans, turning 65 brings a major change in how they pay for health care: Medicare eligibility.
But financial expert Suze Orman says there's a potentially costly misconception about what happens next.
Jeff Bezos backs a platform that lets anyone invest in rental homes for as little as $100 — 6 ways to build wealth like a landlord without actually being one
JPMorgan sees gold hitting $5,000/oz by Q4 — and savvy investors are protecting their wealth with a tax-advantaged Gold IRA. Get your free guide from Priority Gold

#Gold #moneywise

Mondelēz International has substituted rigid polyethylene terephthalate (PET) trays with FSC-certified paper trays across its main cookie lines in Europe within the biscuits segment, according to a press release posted on My News Desk.
The switch applies to more than 115 products sold under eight brands. These include Cadbury, Chips Ahoy!, Freia, Lacta and Marabou.
These items are distributed in more than 25 European countries, including France, Germany, Ireland, the Nordic region, Poland, Spain and the UK.
The project covers approximately 28,000 tonnes of cookies made each year.
Mondelēz estimates the move will cut the use of virgin plastic by 2,200tpa, which is around 80% less than the previous tray format.

#mondel #chips #ahoy #lacta

Moneywise and Yahoo Finance LLC may earn commission or revenue through links in the content below.
CNBC's Rick Santelli has ******* yzed countless economic releases during his decades at the network. But the veteran market commentator could barely contain his surprise when the latest U.S. jobs numbers crossed the screen.
"Hold on to your seats, folks," Santelli said (1) during CNBC's live coverage on the morning of Sept. 4. "Nonfarm payrolls for the month of August: up 162,000. That's basically three times what expectations are."
The official numbers confirmed the magnitude of the surprise. The U.S. economy added 162,000 nonfarm payroll jobs in August, according to the U.S. Bureau of Labor Statistics (2) — more than three times the 53,000 jobs economists had expected (3).
Jeff Bezos backs a platform that lets anyone invest in rental homes for as little as $100 — 6 ways to build wealth like a landlord without actually being one

#moneywise

Nvidia rose only 0.8% on September 4, while Astera Labs jumped 9.8% and Marvell gained 7.1%. The comparison was consistent with investors broadening the AI trade beyond accelerators into connectivity suppliers. Astera's rally also coincided with speculation that the company could be added to the S&P 500, although it was ultimately not selected in the September rebalance. Bigger accelerator clusters need retimers, switches, optical links, and custom silicon to move data without leaving expensive processors idle. Astera Labs, Inc. (NASDAQ:ALAB) and Marvell Technology, Inc. (NASDAQ:MRVL) monetize that connectivity bottleneck from different positions.
Photo from Astera Labs
Astera is the focused rack-scale connectivity play. Its second-quarter update said a Q3 production ramp of the Scorpio X-Series 320-lane fabric switch was expected to drive the next revenue inflection, alongside growth opportunities across Aries, Taurus, and Leo. The bull case is content growth: each new generation of AI rack can require more connectivity silicon and software. The bear case is dependence on a concentrated group of hyperscale customers, product-transition timing, and a valuation that ***** umes strong adoption before every design win becomes revenue.
Hedge-fund breadth strengthened before the rally. Insider Monkey counted 73 funds holding Astera Labs, Inc. (NASDAQ:ALAB) at June 30, up from 53 at March 31. Lee Ainslie's Maverick Capital disclosed 1,067,215 shares, 12% more than in Q1. The quarter-end filing cannot show whether Maverick participated in the September move.
Marvell is more diversified. Its data-center business spans custom compute, electro-optics, switching, and interconnect, giving it multiple ways to benefit as cloud companies redesign AI systems. That breadth is the bull case because one customer's architecture can pull several product families. It is also the risk: custom programs can be lumpy, development costs arrive before revenue, and investors may overestimate the near-term contribution of announced wins.

#september #alab

On August 6, Versant Media Group (NASDAQ:VSNT) reported second-quarter 2026 results that capture a company in transition. Revenue slipped 3.8% year over year to $1.64 billion, and net income attributable to Versant tumbled 30.1% to $211 million. Yet the same report included a raised full-year outlook, a third straight quarterly dividend, and a second $100 million stock buyback. For a company barely eight months removed from its separation from Comcast on January 2, the numbers tell two stories at once.
Versant's headline Adjusted EBITDA fell 8.9% to $624 million, but measured against the prior year's Standalone Adjusted EBITDA, the more relevant apples-to-apples baseline, EBITDA actually grew 3.0%. That gap matters because it shows the company trimming programming and overhead costs faster than legacy revenue is shrinking. Management leaned into that momentum by raising full-year revenue guidance to $6.2 billion to $6.45 billion and Adjusted EBITDA guidance to $1.9 billion to $2.05 billion, while holding free cash flow guidance at $1.0 billion to $1.2 billion.
The growth story lives outside the traditional cable bundle. Platforms revenue, excluding the divested SportsEngine business, climbed 9.3% on the strength of Fandango and GolfNow, and Versant used the quarter to lock in two multi-year distribution renewals with major partners in the US and Canada. Sports rights remain the anchor: PGA TOUR coverage delivered its best second quarter since 2020, USA Network's WNBA broadcasts drew three of the quarter's most watched games across cable and streaming, and a new five-year Bundesliga deal adds more than 300 live matches a year, with at least 30 landing on USA Network. MS NOW backed that up digitally, posting audience growth for a seventh straight month through June and racking up close to 3 billion YouTube and TikTok views so far this year. Layer in the Full Swing acquisition completed after quarter-end, and Versant is placing real bets beyond linear television.
The pressure driving those buybacks and that raised guidance is real. Total revenue fell 3.8% to $1.64 billion, or 2.8% excluding SportsEngine, and linear distribution revenue, still the largest piece of the business, dropped 6.3% as subscribers kept leaving traditional pay TV. Rate increases only partly offset that erosion, and advertising revenue slipped another 0.6% even with better ratings and a boost from a recent acquisition.
The bottom line felt it more than the top line. Net income attributable to Versant fell $91 million to $211 million, and the company pointed to higher costs of running as a standalone public company, new interest expense tied to debt taken on after leaving Comcast, and a bigger tax bill linked to the SportsEngine sale. Those are the direct costs of standing alone rather than sitting inside a larger conglomerate. Versant's prior year financial statements were also built from Comcast's carve out accounting rather than results as a true independent company, so s

Revolution Medicines, Inc. (NASDAQ:RVMD) received FDA approval for Rasonque, or daraxonrasib, following an expedited review. The once-daily oral RAS inhibitor is approved for adults with metastatic pancreatic adenocarcinoma who have received at least one prior systemic therapy or are not candidates for multiagent systemic therapy.
Revolution Medicines, Inc. (NASDAQ:RVMD) set a wholesale acquisition cost (WAC) of $39,800 for a 30-day supply. Twelve 30-day supplies would total $477,600 at WAC before discounts, rebates, or ******* istance. Rasonque is available in the United States, with (ON)Path offering insurance navigation and financial-assistance resources, including copay support for eligible commercially insured patients.
The approval was based on RASolute 302, a randomized Phase 3 trial involving 500 patients with previously treated metastatic pancreatic adenocarcinoma. In the overall population, median overall survival reached 13.2 months with Rasonque versus 6.7 months with chemotherapy. The hazard ratio of 0.40 represented a 60% lower hazard of death during trial follow-up. Median progression-free survival was 7.2 months versus 3.6 months, while objective response rates were 30% and 11%, respectively.
The survival benefit gives Rasonque a strong clinical argument for reimbursement. Pancreatic cancer is aggressive, treatment options after progression are limited, and Rasonque improved overall survival, progression-free survival, and response rates in a randomized comparison. Oral dosing may also reduce the burden of intravenous chemotherapy.
The approved population is broader than a single mutation-defined subgroup. Rasonque can be prescribed with or without an identified RAS tumor mutation and does not require a companion diagnostic. That reduces testing friction within the approved treatment setting.

#months #pancreatic #progression #medicines

With a market cap of $117.8 billion, Medtronic plc (MDT) is a leading global healthcare technology company focused on addressing complex health challenges through innovative medical solutions. With a global workforce serving patients across more than 150 countries, its technologies span cardiac devices, surgical robotics, insulin pumps, surgical tools, and patient monitoring systems.
Companies valued at $10 billion or more are generally considered "large-cap" stocks, and Medtronic fits this criterion perfectly. Guided by its mission to alleviate pain, restore health, and extend life, Medtronic's innovations aim to improve outcomes and transform lives worldwide.
Dear GameStop Stock Fans, Mark Your Calendars for September 8
SMCI vs. CoreWeave: 1 AI Infrastructure Model Has the Bigger Opportunity
Why ******* ysts Think Sellas Life Sciences Stock Can Gain 150% From Here

#Health #surgical #Companies

Nvidia (NVDA) CEO Jensen Huang has a message for investors worried about hyperscaler AI spending: The boom is nowhere near over.
Microsoft (MSFT), Amazon (AMZN), and Alphabet (GOOG) (GOOGL) continue to pour billions into data centers, but some investors fear those enormous capital expenditures could eventually peak and pressure Nvidia's growth.
Dear Sandisk Stock Fans, Mark Your Calendars for August 31
Bill Gates Says 'We Need Time to Prepare' for an Economic Upheaval — Especially the $20-an-Hour Workers Being Replaced by $10-an-Hour Robots
Dear Palantir Stock Fans, Here's What Maven's Billion-Dollar ARR Means for PLTR

#nvda

Moneywise and Yahoo Finance LLC may earn commission or revenue through links in the content below.
If you've read recent headlines, you're probably convinced everyone beyond the age of 60 is extremely rich. After all, the Washington Post (1) called the baby boomers the "wealthiest generation in history" last year.
From gold-plated pensions to excessively large homes, boomers — apparently — have it all.
Jeff Bezos backs a platform that lets anyone invest in rental homes for as little as $100 — 6 ways to build wealth like a landlord without actually being one
JPMorgan sees gold hitting $5,000/oz by Q4 — and savvy investors are protecting their wealth with a tax-advantaged Gold IRA. Get your free guide from Priority Gold

#moneywise #finance #post #bezos

Some offers on this page are from advertisers who pay us, which may affect which products we write about, but not our recommendations. See our Advertiser Disclosure.
Many crypto platforms let you trade digital coins and not much else. Uphold takes a wider swing by letting you trade more than 250 cryptocurrencies, four precious metals, and dozens of national currencies. It even allows you to directly trade one for another.
What makes that possible is what Uphold calls its anything-to-anything model, which moves you directly from bitcoin to gold, or from silver to euros, without forcing a sale in dollars in between. Very few platforms work this way.
That wide selection costs you, though. Uphold folds its fee into a spread on every trade, so the price you see already includes its cut, and that all-in price runs higher than several rivals. You also won't find the advanced trading tools that active traders use or any stocks and exchange-traded funds (ETFs).
Let's take a closer look at what Uphold delivers and where it falls flat based on our hands-on testing.

#uphold #platforms #directly

Some offers on this page are from advertisers who pay us, which may affect which products we write about, but not our recommendations. See our Advertiser Disclosure.
Silver (SI=F) December futures opened at $66.80 per ounce on Monday, August 31, 2026, down 1.4% from Friday's closing price. Silver rose this morning, reaching $67.84 as of 8:39 a.m. ET.
Silver prices have been steadily declining since the start of last week and sank even lower at the open this morning as expectations for a Fed rate increase rise.
On Friday, Fed Chair Kevin Warsh reiterated the Fed's mandate for lowering prices, saying the Fed had "work to do":
"We must be confident that underlying inflation is moving to our objective, clearly and at sufficient speed. Otherwise, we have work to do," Warsh said in his first speech as chairman in Jackson Hole, Wyo. "It is the Fed's job to deliver stable prices."

#prices #warsh #morning #work

Lantronix (NASDAQ:LTRX) closed out fiscal 2026 looking like a different company than it was a year earlier. Revenue for the fourth quarter, which ended June 30 and was reported on August 26, came in at $31.2 million, up 8% from a year ago, while non-GAAP earnings per share jumped 300% to $0.04. The company also finished the year debt-free with $60.5 million in cash. What used to be a niche embedded-connectivity supplier is now leaning hard into drones, edge AI compute, and recurring software revenue.
That shift shows up most clearly in unmanned systems. A year ago the company had roughly 10 active engagements in the category; by the end of fiscal 2026 that number had tripled to over 30. Unmanned systems revenue hit $12.6 million for the year, above the midpoint of the $10 million to $14 million range management had guided to, and embedded IoT solutions overall grew 34% on the strength of that business.
CEO Saleel Awsare pointed to the company's US Army short-range reconnaissance program win, tied to Teal Drones' Black Widow platform and its status as a Blue UAS approved supplier, as proof of its camera tuning and sensor fusion expertise. Management is layering in partnerships too, including a deal with AVT Australia to build its system-on-module tech into gimbal camera payloads and a collaboration with Swarmer that roughly quadruples onboard processing power for Group 1 drones. For fiscal 2027, management expects unmanned systems to reach 15% to 20% of total revenue, more than $25 million.
The balance sheet backs up the ambition: a $44 million capital raise during the quarter helped push cash to $60.5 million while the company paid off its remaining $8.7 million in debt. On top of that, the $11.7 million purchase of Vecima Networks' Industrial IoT business, including the Nero Global Tracking platform and its 125,000 device tags, is expected to add $5.3 million in annual revenue and push software and services to about 10% of total revenue on a pro forma basis, up from 7% to 8% previously.
Not every input is cooperating. CFO Brent Stringham flagged that memory availability has tightened and prices have risen as AI infrastructure and hyperscale data centers absorb a growing share of global supply, a dynamic he described as industry-wide rather than specific to Lantronix. The company's IoT Systems Solutions segment, which grew 16% sequentially to $15.3 million, was still recovering from federal government shutdowns that slowed procurement in the prior two quarters, a reminder of how exposed that business is to Washington's budget calendar. And despite the non-GAAP profit, Lantronix posted a GAAP net loss of $269,000 for the quarter, an improvement from the $2.6 million loss a year earlier but still red ink.

#gaap

When hip-hop icon and Wu-Tang founder Raekwon the Chef marched into the headquarters of Palantir (PLTR) in 2010, he stumbled upon a company that most of us had never heard of.
At that stage, Palantir was just another private Silicon Valley startup. It had a couple hundred employees, a relatively humble valuation of $735 million, and got most of its business through boring government contracts.
Tesla Stock Could Benefit as Trump Locks Down the U.S. Power Grid
Tesla Just Killed Its Solar Roof After Years of Struggling to Scale. What It Means for TSLA Stock.
Dear Palantir Stock Fans, Here's What Maven's Billion-Dollar ARR Means for PLTR

#pltr #means #raekwon

Broadcom (NASDAQ:AVGO) CEO Hock Tan put a number on the company's future months ago, and he has not walked it back. On the chip giant's June 3 earnings call, Tan said the company expects about $56 billion of artificial intelligence (AI) semiconductor revenue this fiscal year, up approximately 180% from fiscal 2025.
And then he went further.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
"We reiterate our AI semiconductor revenue guidance to be in excess of $100 billion" for fiscal 2027, he told ****** ysts.
The business behind the forecast delivered on the same call. AI semiconductor revenue reached $10.8 billion in the fiscal second quarter of 2026 (the period ended May 3), a 143% jump from a year earlier, with guidance calling for $16.0 billion in the third quarter.

#NVIDIA

On the August 26 episode of Mad Money, a caller mentioned that they had purchased 1,000 shares of Moderna, Inc. (NASDAQ:MRNA) at $54 a couple of weeks prior, watched the price go up to $150, and asked what they should do. Jim Cramer replied:
Here's what I would do: I think that you have to take a little bit off. But I have also, because of my daughter who had melanoma and fortunately beat it, done a huge amount of work on the vaccine, and I got to tell you, I would hold on to this stock because I think the vaccine is very for real.
Moderna shares surged 177% on August 19 after the company and Merck & Co. announced that their personalized mRNA cancer vaccine, intismeran autogene, met the primary and key secondary endpoints in a Phase 3 melanoma trial involving 1,137 patients. The result gives Moderna its strongest late-stage evidence yet that its mRNA platform can work as a therapeutic cancer treatment. However, the detailed Phase 3 data have not been released, and investors should not confuse the new results with the 49% reduction in recurrence or death and 59% reduction in distant metastasis or death reported in the earlier Phase 2b study.
The clinical breakthrough arrived well before Moderna, Inc.'s (NASDAQ:MRNA) financial turnaround. The company generated $145 million of second-quarter 2026 revenue and reported a $782 million GAAP net loss, while continuing to target cash breakeven in 2028. It ended June with $6.9 billion of cash, cash equivalents, and investments, although it subsequently paid $950 million related to a litigation settlement.
The bear argument is that Moderna, Inc.'s (NASDAQ:MRNA) stock has repriced faster than the fundamental business has been proven. Its market value increased by tens of billions of dollars following the announcement of a trial whose detailed Phase 3 data remain outstanding. Regulatory approval is still required, while personalized cancer vaccines must overcome significant manufacturing and logistical challenges. Success in melanoma also does not guarantee comparable results in lung, bladder, kidney, or other cancers.

#mrna

Ross Stores, which also operates dd's Discounts, is planning a bold in-store change as it benefits from heightened consumer demand.
The off-price retailer saw its comparable store sales increase by 10% year over year in the second quarter of this year, according to its latest earnings report. Also, its operating profits reached $1.1 billion, up by almost 73% from the previous year.
A recent Placer.ai report revealed that foot traffic at Ross Dress for Less locations spiked by 16.4% year over year, while traffic at dd's Discounts climbed by 8.4%.
"Off-price continues to thrive, with Ross leading the way in the first half of 2026," said Ephraim Fruchter, insights content writer at Placer.ai, in the report. "And with household budgets still under pressure, consumers appear to be rewarding retailers that stretch their dollars furthest."
As Ross sees more consumers flock to its stores, it has grown more comfortable in rolling out price increases, a change that shoppers will soon notice.

#ross

NVIDIA's (NVDA) blowout earnings and guidance – expected 70% revenue growth in 2028 –prove the AI boom is still booming up and down the stack, from energy to data centers. Today I'll show you two AI memory stocks with huge potential.
This is very much a pick and axe story. As AI is deployed, more high-bandwidth memory is required. The winners are the ones receiving institutional support.
Right now, Micron (MU) is the poster child for relentless institutional support. The company builds memory for AI processors and sports a $1 trillion market capitalization.
Memory needs have only increased, and yet the stock has been range-bound:
But that 5.91X forward P/E ratio is incredible. It's one of the cheapest stocks in the market and is projected for huge per-share earnings growth – from $73.23 this year to almost $170 in 2028.

#stocks #institutional #support #today

IBD Composite Rating
Industry Group Ranking
Emerging Pattern

#industry #pattern

In 2025, 87% of all mortgage borrowers paid above the most competitive rate available to them, and 78.7% of refinance borrowers overpaid, typically costing them $3,343 a year, or $278 a month, according to Bankrate's Hidden Homeownership Tax research.
Refinancing isn't free. Expect closing costs of 2% to 5% of your new loan amount, and the savings only outweigh that cost once you cross your break-even point.
While a lower interest rate sounds tempting, keep an eye on fees – they can overwhelm your savings from lower monthly payments.
Despite the rise in interest rates in the last few years, refinancing may still make sense for some homeowners. If you're a first-time refinancer, though, you might have a lot of questions about what the process is like — and might also have picked up some misinformation. Let's dispel some common myths about mortgage refinancing.
Myth

#savings

NVDA's ACIE segment, which covers enterprise, neocloud, and sovereign buyers, hit $40 billion with 138% year-over-year growth, outpacing hyperscaler revenue's 13% sequential gain.
Sovereign AI revenue more than tripled year over year, with neocloud partners targeting eight gigawatts of installed NVIDIA capacity by year-end.
NVIDIA carries $108.5 billion in guarantee obligations for neocloud partners, and days sales outstanding jumped from 45 to 60 days, signaling elevated financing risk.
Read More: Learn 7 secret wealth tips high net worth investors use that most investors miss (sponsor)
NVIDIA (NASDAQ:NVDA) delivered $89.023 billion of Data Center revenue in its most recent fiscal second quarter, but the customer mix beneath that number may matter more than the record itself. Direct hyperscaler sales totaled $49 billion, up 13% sequentially. ACIE, covering AI cloud providers, industrial customers, enterprises and sovereign buyers, reached $40 billion after 25% sequential growth and 138% year-over-year growth. Management expects ACIE to drive most of next quarter's Data Center growth before hyperscale reaccelerates as Vera Rubin supply improves. That is a striking rebalancing for a company long described as dependent on a handful of technology giants.

#year #sovereign #center

Fluence Energy (NASDAQ:FLNC) shares jumped 8.7% in pre-market trading after UBS upgraded the energy storage company to Neutral from Sell and raised its price target to $12.00 from $9.00.
The change represents a significant shift in stance from one of the more bearish institutional ***** ysts covering Fluence. UBS reassessed its outlook following a period of heavy selling pressure that had pushed the stock sharply lower after the company's recent earnings.
A key factor behind the upgrade was UBS's revised financial model, which now forecasts Fluence Energy revenue growing at a five-year compound annual rate of 22% through 2030.
The bank expects increasing demand for battery storage, particularly within hybrid projects combining solar generation with energy storage, to support the company's longer-term expansion.
UBS also revised its adjusted EBITDA forecasts for fiscal 2026, 2027 and 2028. Importantly, the bank concluded that some revenue previously expected in the current financial year had been delayed into the following period rather than permanently lost.

#fluence #revenue

When ****** sing the leaders of the artificial intelligence (AI) boom, Nvidia Corporation (NVDA) continues to be the most challenging stock for investors to bet against. Wolfe Research, an independent equity research firm, has reinforced this view by selecting Nvidia as its top AI semiconductor pick ahead of the company's upcoming earnings report.
Analyst Chris Caso remains "broadly bullish" on AI semiconductor stocks, particularly as major technology companies continue to commit enormous amounts of capital to AI infrastructure. The firm said the broader AI semiconductor backdrop remains strong, pointing to upward revisions in capital expenditure and supportive supply-chain data as signs that spending on AI infrastructure is still accelerating.
IonQ vs. Rigetti: The Better Quantum Computing Stock for Long-Term Investors
Stocks Set to Open Lower as Chipmakers Get Hit, Nvidia Earnings and Warsh's Jackson Hole Speech Awaited
Fabrinet Just Lost Billions in Market Value Due to Nvidia. Here's Why the Reaction Is Overdone.

#semiconductor #Research #stocks

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) was up 7.5% in after-hours trading as of approximately 5:33 p.m. ET Wednesday after the FDA approved Genglycos for glycogen storage disease type Ia, or GSDIa. The one-time gene therapy is the first approved treatment designed to address the disorder's underlying cause. It will carry a U.S. list price of approximately $2.7 million per patient and is expected to become available through qualified treatment centers within 30 to 60 days.
The approval gives Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) first-mover status in a disease the company estimates affects only 1,500 to 2,500 Americans. The commercial question is whether a high-priced treatment for an ultra-rare population can produce meaningful revenue after diagnosis, reimbursement, and treatment-center constraints.
GSDIa prevents the liver from releasing glucose properly, leaving patients dependent on frequent raw-cornstarch doses to avoid potentially life-threatening hypoglycemia. In the Phase 3 GlucoGene trial, Genglycos reduced mean daily cornstarch intake by 41% at Week 48, compared with 10% for placebo, while maintaining glucose control. For Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), reducing that daily burden creates a clear argument for premium pricing.
Longer-term data also support the treatment's potential durability. At Week 96, the original-treatment group reported a 61% mean reduction from baseline, while the crossover group reported a 61% reduction from Week 48, when it began treatment. Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) will manufacture the therapy at its Bedford, Massachusetts, facility, giving the company direct control over an important part of the supply chain.
The launch will also test infrastructure that could support future gene therapies. Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) already sells rare-disease products including Crysvita, Dojolvi, Evkeeza and Mepsevii. Second-quarter revenue reached $214 million, while cash, cash equivalents, and marketable securities totaled $436 million as of June 30. Genglycos therefore enters a functioning commercial organization rather than a first-time launch platform.

#treatment